Abstract
Cancer cells often change their metabolism to support uncontrolled proliferation. Proline is the only proteogenic secondary amino acid that is abundant in the body. Recent studies have shown that proline metabolism plays an important role in metabolic reprogramming and affects the occurrence and development of cancer. Proline metabolism is related to ATP production, protein and nucleotide synthesis, and redox homeostasis in tumor cells. Proline can be synthesized by aldehyde dehydrogenase family 18 member A1 (ALDH18A1) and delta1-pyrroline-5-carboxylate reductase (PYCR), up-regulating ALDH18A1 and PYCR can promote the proliferation and invasion of cancer cells. As the main storage of proline, collagen can influence cancer cells proliferation, invasion, and metastasis. Its synthesis depends on the hydroxylation of proline catalyzed by prolyl 4-hydroxylases (P4Hs), which will affect the plasticity and metastasis of cancer cells. The degradation of proline occurs in the mitochondria and involves an oxidation step catalyzed by proline dehydrogenase/proline oxidase (PRODH/POX). Proline catabolism has a dual role in cancer, linking apoptosis with the survival and metastasis of cancer cells. In addition, it has been demonstrated that the regulation of proline metabolic enzymes at the genetic and post-translational levels is related to cancer. This article reviews the role of proline metabolic enzymes in cancer proliferation, apoptosis, metastasis, and development. Research on proline metabolism may provide a new strategy for cancer treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams E (1970) Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res 5:1–91. https://doi.org/10.1016/b978-0-12-363705-5.50007-5
Annunen P, Helaakoski T, Myllyharju J, Veijola J, Pihlajaniemi T, Kivirikko KI (1997) Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II)beta2 tetramer. J Biol Chem 272(28):17342–17348. https://doi.org/10.1074/jbc.272.28.17342
Cai F, Miao Y, Liu C, Wu T, Shen S, Su X, Shi Y (2018) Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Oncol Lett 15(1):731–740. https://doi.org/10.3892/ol.2017.7400
Cao XP, Cao Y, Li WJ, Zhang HH, Zhu ZM (2019) P4HA1/HIF1alpha feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer. Biochem Biophys Res Commun 516(3):606–612. https://doi.org/10.1016/j.bbrc.2019.06.096
Chen S, Yang X, Yu M, Wang Z, Liu B, Liu M, Liu L, Ren M, Qi H, Zou J, Vucenik I, Zhu WG, Luo J (2019) SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism. Neoplasia 21(7):665–675. https://doi.org/10.1016/j.neo.2019.04.008
Choi UY, Lee JJ, Park A, Zhu W, Lee HR, Choi YJ, Yoo JS, Yu C, Feng P, Gao SJ, Chen S, Eoh H, Jung JU (2020) Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis. Proc Natl Acad Sci USA 117(14):8083–8093. https://doi.org/10.1073/pnas.1918607117
Comes S, Gagliardi M, Laprano N, Fico A, Cimmino A, Palamidessi A, De Cesare D, De Falco S, Angelini C, Scita G, Patriarca EJ, Matarazzo MR, Minchiotti G (2013) L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation. Stem Cell Rep 1(4):307–321. https://doi.org/10.1016/j.stemcr.2013.09.001
D’Aniello C, Cermola F, Patriarca EJ, Minchiotti G (2017) Vitamin C in stem cell biology: impact on extracellular matrix homeostasis and epigenetics. Stem Cells Int 2017:8936156. https://doi.org/10.1155/2017/8936156
D’Aniello C, Cermola F, Palamidessi A, Wanderlingh LG, Gagliardi M, Migliaccio A, Varrone F, Casalino L, Matarazzo MR, De Cesare D, Scita G, Patriarca EJ, Minchiotti G (2019) Collagen prolyl hydroxylation-dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and cancer cells. Cancer Res 79(13):3235–3250. https://doi.org/10.1158/0008-5472.CAN-18-2070
DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200. https://doi.org/10.1126/sciadv.1600200
Ding J, Kuo ML, Su L, Xue L, Luh F, Zhang H, Wang J, Lin TG, Zhang K, Chu P, Zheng S, Liu X, Yen Y (2017) Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Carcinogenesis 38(5):519–531. https://doi.org/10.1093/carcin/bgx022
Ding Z, Ericksen RE, Escande-Beillard N, Lee QY, Loh A, Denil S, Steckel M, Haegebarth A, Wai Ho TS, Chow P, Toh HC, Reversade B, Gruenewald S, Han W (2020) Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. J Hepatol 72(4):725–735. https://doi.org/10.1016/j.jhep.2019.10.026
Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, Phang JM (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 61(5):1810–1815
Du S, Sui Y, Ren W, Zhou J, Du C (2021) PYCR1 promotes bladder cancer by affecting the Akt/Wnt/beta-catenin signaling. J Bioenerg Biomembr 53(2):247–258. https://doi.org/10.1007/s10863-021-09887-3
Dunphy MPS, Harding JJ, Venneti S, Zhang HW, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, Weber W, Lyashchenko SK, Kung HF, Lewis JS (2018) In vivo PET assay of tumor glutamine flux and metabolism: in-human trial of F-18-(2S,4R)-4-fluoroglutamine. Radiology 287(2):667–675. https://doi.org/10.1148/radiol.2017162610
Elia I, Broekaert D, Christen S, Boon R, Radaelli E, Orth MF, Verfaillie C, Grunewald TGP, Fendt SM (2017) Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun 8:15267. https://doi.org/10.1038/ncomms15267
Elia I, Rossi M, Stegen S, Broekaert D, Doglioni G, van Gorsel M, Boon R, Escalona-Noguero C, Torrekens S, Verfaillie C, Verbeken E, Carmeliet G, Fendt SM (2019) Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature 568(7750):117–121. https://doi.org/10.1038/s41586-019-0977-x
Fang E, Wang X, Yang F, Hu A, Wang J, Li D, Song H, Hong M, Guo Y, Liu Y, Li H, Huang K, Zheng L, Tong Q (2019) Therapeutic targeting of MZF1-AS1/PARP1/E2F1 axis inhibits proline synthesis and neuroblastoma progression. Adv Sci (weinh) 6(19):1900581. https://doi.org/10.1002/advs.201900581
Gilkes DM, Chaturvedi P, Bajpai S, Wong CC, Wei H, Pitcairn S, Hubbi ME, Wirtz D, Semenza GL (2013) Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res 73(11):3285–3296. https://doi.org/10.1158/0008-5472.CAN-12-3963
Guo L, Cui C, Zhang K, Wang J, Wang Y, Lu Y, Chen K, Yuan J, Xiao G, Tang B, Sun Y, Wu C (2019) Kindlin-2 links mechano-environment to proline synthesis and tumor growth. Nat Commun 10(1):845. https://doi.org/10.1038/s41467-019-08772-3
Guo L, Cui C, Wang J, Yuan J, Yang Q, Zhang P, Su W, Bao R, Ran J, Wu C (2020) PINCH-1 regulates mitochondrial dynamics to promote proline synthesis and tumor growth. Nat Commun 11(1):4913. https://doi.org/10.1038/s41467-020-18753-6
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
He QH, Yin YL, Zhao F, Kong XF, Wu GY, Ren PP (2011) Metabonomics and its role in amino acid nutrition research. Front Biosci Landmrk 16:2451–2460. https://doi.org/10.2741/3865
Hu CA, Khalil S, Zhaorigetu S, Liu Z, Tyler M, Wan G, Valle D (2008) Human Delta1-pyrroline-5-carboxylate synthase: function and regulation. Amino Acids 35(4):665–672. https://doi.org/10.1007/s00726-008-0075-0
Johnson AB, Strecker HJ (1962) The interconversion of glutamic acid and proline. IV. The oxidation of proline by rat liver mitochondria. J Biol Chem 237:1876–1882
Kardos GR, Wastyk HC, Robertson GP (2015) Disruption of proline synthesis in melanoma inhibits protein production mediated by the GCN2 pathway. Mol Cancer Res 13(10):1408–1420. https://doi.org/10.1158/1541-7786.MCR-15-0048
Li Q, Wang Q, Zhang Q, Zhang J, Zhang J (2019) Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer. Am J Transl Res 11(11):6938–6951
Li Y, Bie J, Song C, Liu M, Luo J (2021) PYCR, a key enzyme in proline metabolism, functions in tumorigenesis. Amino Acids. https://doi.org/10.1007/s00726-021-03047-y
Liu W, Phang JM (2012) Proline dehydrogenase (oxidase) in cancer. BioFactors 38(6):398–406. https://doi.org/10.1002/biof.1036
Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM (2006) Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25(41):5640–5647. https://doi.org/10.1038/sj.onc.1209564
Liu Y, Borchert GL, Surazynski A, Phang JM (2008) Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 27(53):6729–6737. https://doi.org/10.1038/onc.2008.322
Liu Y, Borchert GL, Donald SP, Diwan BA, Anver M, Phang JM (2009) Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res 69(16):6414–6422. https://doi.org/10.1158/0008-5472.CAN-09-1223
Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S, Anderson LM, Perantoni AO, Phang JM (2010) miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29(35):4914–4924. https://doi.org/10.1038/onc.2010.237
Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A, Phang JM (2012a) Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res 72(14):3677–3686. https://doi.org/10.1158/0008-5472.CAN-12-0080
Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM (2012b) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci USA 109(23):8983–8988. https://doi.org/10.1073/pnas.1203244109
Liu W, Hancock CN, Fischer JW, Harman M, Phang JM (2015) Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides. Sci Rep 5:17206. https://doi.org/10.1038/srep17206
Liu Y, Wu L, Li K, Liu F, Wang L, Zhang D, Zhou J, Ma X, Wang S, Yang S (2019) Ornithine aminotransferase promoted the proliferation and metastasis of non-small cell lung cancer via upregulation of miR-21. J Cell Physiol 234(8):12828–12838. https://doi.org/10.1002/jcp.27939
Liu M, Wang Y, Yang C, Ruan Y, Bai C, Chu Q, Cui Y, Chen C, Ying G, Li B (2020a) Inhibiting both proline biosynthesis and lipogenesis synergistically suppresses tumor growth. J Exp Med. https://doi.org/10.1084/jem.20191226
Liu Y, Mao C, Wang M, Liu N, Ouyang L, Liu S, Tang H, Cao Y, Liu S, Wang X, Xiao D, Chen C, Shi Y, Yan Q, Tao Y (2020b) Cancer progression is mediated by proline catabolism in non-small cell lung cancer. Oncogene 39(11):2358–2376. https://doi.org/10.1038/s41388-019-1151-5
Ma X, Wang J, Zhuang J, Ma X, Zheng N, Song Y, Xia W (2020) P4HB modulates epithelial-mesenchymal transition and the beta-catenin/Snail pathway influencing chemoresistance in liver cancer cells. Oncol Lett 20(1):257–265. https://doi.org/10.3892/ol.2020.11569
Myllyharju J (2003) Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol 22(1):15–24. https://doi.org/10.1016/s0945-053x(03)00006-4
Myllyharju J (2008) Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets. Ann Med 40(6):402–417. https://doi.org/10.1080/07853890801986594
Myllyharju J, Kivirikko KI (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20(1):33–43. https://doi.org/10.1016/j.tig.2003.11.004
Natarajan SK, Zhu W, Liang X, Zhang L, Demers AJ, Zimmerman MC, Simpson MA, Becker DF (2012) Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death. Free Radic Biol Med 53(5):1181–1191. https://doi.org/10.1016/j.freeradbiomed.2012.07.002
Olivares O, Mayers JR, Gouirand V, Torrence ME, Gicquel T, Borge L, Lac S, Roques J, Lavaut MN, Berthezene P, Rubis M, Secq V, Garcia S, Moutardier V, Lombardo D, Iovanna JL, Tomasini R, Guillaumond F, Vander Heiden MG, Vasseur S (2017) Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun 8:16031. https://doi.org/10.1038/ncomms16031
Ou R, Zhang X, Cai J, Shao X, Lv M, Qiu W, Xuan X, Liu J, Li Z, Xu Y (2016) Downregulation of pyrroline-5-carboxylate reductase-2 induces the autophagy of melanoma cells via AMPK/mTOR pathway. Tumour Biol 37(5):6485–6491. https://doi.org/10.1007/s13277-015-3927-8
Pandhare J, Cooper SK, Phang JM (2006) Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem 281(4):2044–2052. https://doi.org/10.1074/jbc.M507867200
Pandhare J, Donald SP, Cooper SK, Phang JM (2009) Regulation and function of proline oxidase under nutrient stress. J Cell Biochem 107(4):759–768. https://doi.org/10.1002/jcb.22174
Phang JM, Liu W (2012) Proline metabolism and cancer. Front Biosci (landmark Ed) 17:1835–1845. https://doi.org/10.2741/4022
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389(6648):300–305. https://doi.org/10.1038/38525
Ricard-Blum S (2011) The collagen family. Cold Spring Harb Perspect Biol 3(1):a004978. https://doi.org/10.1101/cshperspect.a004978
Sang S, Zhang C, Shan J (2019) Pyrroline-5-carboxylate reductase 1 accelerates the migration and invasion of nonsmall cell lung cancer in vitro. Cancer Biother Radiopharm 34(6):380–387. https://doi.org/10.1089/cbr.2019.2782
Tang L, Zeng J, Geng P, Fang C, Wang Y, Sun M, Wang C, Wang J, Yin P, Hu C, Guo L, Yu J, Gao P, Li E, Zhuang Z, Xu G, Liu Y (2018) Global metabolic profiling identifies a pivotal role of proline and hydroxyproline metabolism in supporting hypoxic response in hepatocellular carcinoma. Clin Cancer Res 24(2):474–485. https://doi.org/10.1158/1078-0432.CCR-17-1707
Togashi Y, Arao T, Kato H, Matsumoto K, Terashima M, Hayashi H, de Velasco MA, Fujita Y, Kimura H, Yasuda T, Shiozaki H, Nishio K (2014) Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production. Oncotarget 5(10):2962–2973. https://doi.org/10.18632/oncotarget.1561
Tran DH, Kesavan R, Rion H, Soflaee MH, Solmonson A, Bezwada D, Vu HS, Cai F, Phillips JA 3rd, DeBerardinis RJ, Hoxhaj G (2021) Mitochondrial NADP(+) is essential for proline biosynthesis during cell growth. Nat Metab 3(4):571–585. https://doi.org/10.1038/s42255-021-00374-y
Wang D, Wang L, Zhang Y, Yan Z, Liu L, Chen G (2019) PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488. Biomed Pharmacother 111:588–595. https://doi.org/10.1016/j.biopha.2018.12.089
Wang X, Bai Y, Zhang F, Yang Y, Feng D, Li A, Yang Z, Li D, Tang Y, Wei X, Wei W, Han P (2020) Targeted inhibition of P4HB promotes cell sensitivity to gemcitabine in urothelial carcinoma of the bladder. Onco Targets Ther 13:9543–9558. https://doi.org/10.2147/OTT.S267734
Xia W, Zhuang J, Wang G, Ni J, Wang J, Ye Y (2017) P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition. Oncotarget 8(5):8512–8521. https://doi.org/10.18632/oncotarget.14337
Xiong G, Deng L, Zhu J, Rychahou PG, Xu R (2014) Prolyl-4-hydroxylase alpha subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer 14:1. https://doi.org/10.1186/1471-2407-14-1
Xiong G, Stewart RL, Chen J, Gao T, Scott TL, Samayoa LM, O’Connor K, Lane AN, Xu R (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1alpha stabilization and TNBC chemoresistance. Nat Commun 9(1):4456. https://doi.org/10.1038/s41467-018-06893-9
Xu S, Xu H, Wang W, Li S, Li H, Li T, Zhang W, Yu X, Liu L (2019) The role of collagen in cancer: from bench to bedside. J Transl Med 17(1):309. https://doi.org/10.1186/s12967-019-2058-1
Yasuda T, Kaji Y, Agatsuma T, Niki T, Arisawa M, Shuto S, Ariga H, Iguchi-Ariga SM (2013) DJ-1 cooperates with PYCR1 in cell protection against oxidative stress. Biochem Biophys Res Commun 436(2):289–294. https://doi.org/10.1016/j.bbrc.2013.05.095
Zabirnyk O, Liu W, Khalil S, Sharma A, Phang JM (2010) Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis 31(3):446–454. https://doi.org/10.1093/carcin/bgp299
Zeng T, Zhu L, Liao M, Zhuo W, Yang S, Wu W, Wang D (2017) Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer. Med Oncol 34(2):27. https://doi.org/10.1007/s12032-016-0870-5
Zhou Y, Yang J, Zhang Q, Xu Q, Lu L, Wang J, Xia W (2019) P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling. Mol Med Rep 19(1):231–237. https://doi.org/10.3892/mmr.2018.9660
Zhu J, Schworer S, Berisa M, Kyung YJ, Ryu KW, Yi J, Jiang X, Cross JR, Thompson CB (2021) Mitochondrial NADP(H) generation is essential for proline biosynthesis. Science. https://doi.org/10.1126/science.abd5491
Zhuang J, Song Y, Ye Y, He S, Ma X, Zhang M, Ni J, Wang J, Xia W (2019) PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer. J Transl Med 17(1):343. https://doi.org/10.1186/s12967-019-2091-0
Zigmond E, Ben Ya’acov A, Lee H, Lichtenstein Y, Shalev Z, Smith Y, Zolotarov L, Ziv E, Kalman R, Le HV, Lu H, Silverman RB, Ilan Y (2015) Suppression of hepatocellular carcinoma by inhibition of overexpressed ornithine aminotransferase. ACS Med Chem Lett 6(8):840–844. https://doi.org/10.1021/acsmedchemlett.5b00153
Acknowledgements
This research was supported by the foundations (21934006, 21876169) from the National Natural Science Foundation of China.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no potential conflict of interest regarding the publication of this article.
Ethical statements
This review article does not involve any human participants and animal work.
Additional information
Handling editor: J. M. Phang.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
